Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Hosted on MSN16d
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes PatientsThis approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have kidney ...
The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO). The medication is ...
Using patient kidney biopsies, the team developed a new method to measure glycocalyx thickness, confirming that the layer is ...
Medical Xpress on MSN11d
Yo-yo dieting may significantly increase kidney disease risk in people with type 1 diabetesBody-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...
THE RESULTS ARE PROMISING FOR HEART PATIENTS ... 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to reduce certain risks associated with chronic kidney disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results